Citations

Showing 10 of 108104 citations.

ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions
Zuberi, Sameer M. , Wirrell, Elaine , Yozawitz, Elissa , Wilmshurst, Jo M. , Specchio, Nicola , Riney, Kate , Pressler, Ronit , Auvin, Stéphane , Samia, Pauline , Hirsch, Édouard , Galicchio, Santiago , Triki, Chahnez , Snead, O. Carter , Wiebe, Samuel , Cross, J. Helen , Scheffer, Ingrid E. , Perucca, Emilio , Nabbout, Rima , Scheffer, Ingrid E , Perucca, Emilio , Moshé, Solomon L , Nabbout, Rima , Wilmshurst, Jo M , Wirrell, Elaine C , Auvin, Stéphane , Yozawitz, Elissa G , Hirsch, Edouard , Cross, Helen J , Samia, Pauline , Specchio, Nicola , Zuberi, Sameer M , Triki, Chahnez , Wiebe, Samuel , Tinuper, Paolo , Moshé, Solomon L.

Mayo Clinic

Epilepsia | May 3, 2022 | Volume: 63 | Issue: 6 | Pages: 1349-1397

10.1111/epi.17239 | PMID 35503712 Get It

Abstract The International League Against Epilepsy (ILAE) Task Force on Nosology and Definitions proposes a classification and definition of epilepsy syndromes in the neonate and infant with seizure onset up to 2 years of age. The incidence of epilepsy is high in this age group and epilepsy is frequently associated with significant comorbidities and mortality. The licensing of syndrome specific antiseizure medications following randomized controlled trials and the development of precision, gene‐related therapies are two of the drivers defining the electroclinical phenotypes of syndromes with onset in infancy. The principal aim of this proposal, consistent with the 2017 ILAE Classification of the Epilepsies, is to support epilepsy diagnosis and emphasize the importance of classifying epilepsy in an individual both by syndrome and etiology. For each syndrome, we report epidemiology, clinical course, seizure types, electroencephalography (EEG), neuroimaging, genetics, and differential diagnosis. Syndromes are separated into self‐limited syndromes, where there is likely to be spontaneous remission and developmental and epileptic encephalopathies , diseases where there is developmental impairment related to both the underlying etiology independent of epileptiform activity and the epileptic encephalopathy. The emerging class of etiology‐specific epilepsy syndromes, where there is a specific etiology for the epilepsy that is associated with a clearly defined, relatively uniform, and distinct clinical phenotype in most affected individuals as well as consistent EEG, neuroimaging, and/or genetic correlates, is presented. The number of etiology‐defined syndromes will continue to increase, and these newly described syndromes will in time be incorporated into this classification. The tables summarize mandatory features, cautionary alerts, and exclusionary features for the common syndromes. Guidance is given on the criteria for syndrome diagnosis in resource‐limited regions where laboratory confirmation, including EEG, MRI, and genetic testing, might not be available.
ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions
Hirsch, Édouard , French, Jacqueline A. , Scheffer, Ingrid E. , Bogacz, Alicia, Alsaadi, Taoufik , Sperling, Michael R. , Abdulla, Fatema , Zuberi, Sameer M. , Trinka, Eugen , Specchio, Nicola , Somerville, Ernest , Riney, Kate , Nabbout, Rima , Jain, Satish, Wilmshurst, Jo M. , Wiebe, Samuel , Perucca, Emilio , Connolly, Mary , Kochen, Silvia , French, Jacqueline , Samia, Pauline , Nabbout, Rima , Wilmshurst, Jo M , Auvin, Stéphane , Wiebe, Samuel , Perucca, Emilio , Moshé, Solomon L , Wirrell, Elaine C , Sperling, Michael R , Hirsch, Edouard , Scheffer, Ingrid E , Trinka, Eugen , Somerville, Ernest , Specchio, Nicola , Zuberi, Sameer M , Samia, Pauline , Jain, Satish, Auvin, Stéphane , Moshé, Solomon L. , Tinuper, Paolo , Wirrell, Elaine

Mayo Clinic

Epilepsia | May 3, 2022 | Volume: 63 | Issue: 6 | Pages: 1475-1499

10.1111/epi.17236 | PMID 35503716 Get It

Abstract In 2017, the International League Against Epilepsy (ILAE) Classification of Epilepsies described the “genetic generalized epilepsies” (GGEs), which contained the “idiopathic generalized epilepsies” (IGEs). The goal of this paper is to delineate the four syndromes comprising the IGEs, namely childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, and epilepsy with generalized tonic–clonic seizures alone. We provide updated diagnostic criteria for these IGE syndromes determined by the expert consensus opinion of the ILAE’s Task Force on Nosology and Definitions (2017–2021) and international external experts outside our Task Force. We incorporate current knowledge from recent advances in genetic, imaging, and electroencephalographic studies, together with current terminology and classification of seizures and epilepsies. Patients that do not fulfill criteria for one of these syndromes, but that have one, or a combination, of the following generalized seizure types: absence, myoclonic, tonic‐clonic and myoclonic‐tonic‐clonic seizures, with 2.5–5.5 Hz generalized spike‐wave should be classified as having GGE. Recognizing these four IGE syndromes as a special grouping among the GGEs is helpful, as they carry prognostic and therapeutic implications.
International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions
Specchio, Nicola , Wirrell, Elaine , Scheffer, Ingrid E. , Nabbout, Rima , Riney, Kate , Samia, Pauline , Guerreiro, Marilisa M. , Gwer, Sam, Zuberi, Sameer M. , Wilmshurst, Jo M. , Yozawitz, Elissa , Pressler, Ronit , Wiebe, Samuel , Cross, J. Helen , Perucca, Emilio , Wirrell, Elaine C , Hirsch, Edouard , Wiebe, Samuel , Cross, Helen J , Perucca, Emilio , Moshé, Solomon L , Auvin, Stéphane , Wilmshurst, Jo M , Yozawitz, Elissa G , Samia, Pauline , Scheffer, Ingrid E , Specchio, Nicola , Zuberi, Sameer M , Gwer, Samson , Hirsch, Édouard , Moshé, Solomon L. , Tinuper, Paolo , Auvin, Stéphane

Mayo Clinic

Epilepsia | May 3, 2022 | Volume: 63 | Issue: 6 | Pages: 1398-1442

10.1111/epi.17241 | PMID 35503717 Get It

Abstract The 2017 International League Against Epilepsy classification has defined a three‐tier system with epilepsy syndrome identification at the third level. Although a syndrome cannot be determined in all children with epilepsy, identification of a specific syndrome provides guidance on management and prognosis. In this paper, we describe the childhood onset epilepsy syndromes, most of which have both mandatory seizure type(s) and interictal electroencephalographic (EEG) features. Based on the 2017 Classification of Seizures and Epilepsies, some syndrome names have been updated using terms directly describing the seizure semiology. Epilepsy syndromes beginning in childhood have been divided into three categories: (1) self‐limited focal epilepsies, comprising four syndromes: self‐limited epilepsy with centrotemporal spikes, self‐limited epilepsy with autonomic seizures, childhood occipital visual epilepsy, and photosensitive occipital lobe epilepsy; (2) generalized epilepsies, comprising three syndromes: childhood absence epilepsy, epilepsy with myoclonic absence, and epilepsy with eyelid myoclonia; and (3) developmental and/or epileptic encephalopathies, comprising five syndromes: epilepsy with myoclonic–atonic seizures, Lennox–Gastaut syndrome, developmental and/or epileptic encephalopathy with spike‐and‐wave activation in sleep, hemiconvulsion–hemiplegia–epilepsy syndrome, and febrile infection‐related epilepsy syndrome. We define each, highlighting the mandatory seizure(s), EEG features, phenotypic variations, and findings from key investigations.
Postprandial symptoms in patients with symptoms of gastroparesis: roles of gastric emptying and accommodation
Parkman, Henry P. , Natta, Mark L. Van , Maurer, Alan H. , Koch, Kenneth L. , Grover, Madhusudan , Malik, Zubair , Sarosiek, Irene , Bulat, Robert, Shulman, Robert J. , Farrugia, Gianrico , Miriel, Laura , Tonascia, James , Hamilton, Frank A., Pasricha, Pankaj J. , McCallum, Richard W. , Farrugia, Gianrico , Parkman, H P , Abell, Thomas L. , Kuo, Braden

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | May 3, 2022 | Volume: 323 | Issue: 1 | Pages: G44-G59

10.1152/ajpgi.00278.2021 | PMID 35502871 Get It

Patients with delayed and normal gastric emptying (GE) had similar symptom profiles during gastric emptying scintigraphy (GES). Idiopathic patients with symptoms of gastroparesis had less gastric retention by GES; but more symptoms after GES meal and after water load satiety test (WLST) compared with diabetic patients. In patients with symptoms of gastroparesis, symptoms after WLST increased with decreasing water consumption. Early satiety and loss of appetite were associated with decreased water consumption during WLST. Thus, impaired accommodation and perhaps visceral hypersensitivity are important in explaining postprandial symptoms in gastroparesis.
Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation
Camilleri, Michael , Magnus, Yorick, Carlson, Paula, Chedid, Victor , Maselli, Daniel B. , Taylor, Ann, McKinzie, Sanna, Nagaraj, Nagaswaroop Kengunte , Busciglio, Irene, Nair, Asha, Kengunte Nagaraj, Nagaswaroop, Chedid, Victor G , Wang, Xiao‐Jing

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | May 3, 2022 | Volume: 323 | Issue: 2 | Pages: G88-G101

10.1152/ajpgi.00063.2022 | PMID 35502856 Get It

This study compares gene expression in mucosa of the terminal ileum, right colon, and left colon in patients with diarrhea- or constipation-predominant irritable bowel syndrome (IBS) and contrasts expression between these two disease entities and also between each entity and mucosa from healthy controls. The study shows there is differential expression of genes related to immune, transmitter, nociceptive, ion channel, and transporter functions, as well as reduced serine protease inhibition, in patients with IBS.
U.S. Occupational Historical Perspective on Race and Lung Function
Townsend, Mary C., Cowl, Clayton T.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 3, 2022 | Volume: 206 | Issue: 6 | Pages: 789-790

10.1164/rccm.202203-0565le | PMID 35503517 Get It

A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022
Gupta, Ravi Kumar, Gupta, Ashish , Hillengaß, Jens , Holstein, Sarah A. , Suman, Vera J. , Taneja, Alankrita , McCarthy, Philip L.

Mayo Clinic

Expert Review of Anticancer Therapy | May 3, 2022 | Volume: 22 | Issue: 5 | Pages: 457-469

10.1080/14737140.2022.2069564 | PMID 35503516 Get It

Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds
McCarter, Stuart J. , Lesnick, Timothy G. , Lowe, Val J. , Przybelski, Scott A. , Jack, Clifford R. , Petersen, Ronald C. , Kantarci, Kejal , Vemuri, Prashanthi , Graff‐Radford, Jonathan , Jack, Clifford R , Vemuri, Prashanthi , Kantarci, Kejal , McCarter, Stuart J , Rabinstein, Alejandro A. , Algeciras‐Schimnich, Alicia , Ramanan, Vijay K. , Knopman, David S. , Boeve, Bradley F. , Mielke, Michelle M.

Mayo Clinic

Journal of Alzheimer's Disease | May 3, 2022 | Volume: 87 | Issue: 4 | Pages: 1537-1547

10.3233/jad-220158 | PMID 35527558 Get It

Background: Cerebral microbleeds (CMBs) are a common vascular pathology associated with future intracerebral hemorrhage. Plasma biomarkers of amyloid, tau, and neurodegeneration may provide a screening avenue to identify those with CMBs, but evidence is conflicting. Objective: To determine the association between plasma biomarkers (Aβ40, Aβ42, t-tau, p-tau181, p-tau217, neurofilament light chain (NfL)) and CMBs in a population-based study of aging and whether these biomarkers predict higher signal on Aβ-PET imaging in patients with multiple CMBs. Methods: 712 participants from the Mayo Clinic Study of Aging with T2* GRE MRI and plasma biomarkers were included. Biomarkers were analyzed utilizing Simoa (Aβ40, Aβ42, t-tau, NfL) or Meso Scale Discovery (p-tau181, p-tau217) platforms. Cross-sectional associations between CMBs, plasma biomarkers and Aβ-PET were evaluated using hurdle models and multivariable regression models. Results: Among the 188 (26%) individuals with≥1 CMB, a lower plasma Aβ42/Aβ40 ratio was associated with more CMBs after adjusting for covariables (IRR 568.5 95% CI 2.8–116,127). No other biomarkers were associated with risk or number CMBs. In 81 individuals with≥2 CMBs, higher plasma t-tau, p-tau181, and p-tau217 all were associated with higher Aβ-PET signal, with plasma p-tau217 having the strongest predictive value (r2 0.603, AIC –53.0). Conclusion: Lower plasma Aβ42/Aβ40 ratio and higher plasma p-tau217 were associated with brain amyloidosis in individuals with CMBs from the general population. Our results suggest that in individuals with multiple CMBs and/or lobar intracranial hemorrhage that a lower plasma Aβ42/Aβ40 ratio or elevated p-tau217 may indicate underlying cerebral amyloid angiopathy.
CPI Cardiac Imaging Special Edition Module
Jokerst, Clinton E., Kallianos, Kimberly, Lu, Jimmy C., Sundaram, Baskaran, Tailor, Tina D., Jokerst, Clinton E., Kallianos, Kimberly, Lu, Jimmy C., Sundaram, Baskaran, Tailor, Tina D.

Mayo Clinic

Continuous Professional Improvement | May 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.54057/cpi.cd2021 Get It

CPI Gastrointestinal Tract Radiology Module 2020
Hansen, Neil J., Wells, Shane A. , Yano, Motoyo , Baheti, Akshay , Revels, Jonathan , Stein, Erica B. , Zafar, Hanna M.

Mayo Clinic

Continuous Professional Improvement | May 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.54057/cpi.gi2020 Get It